Ortho Biotech Company Description
Ortho Biotech Products isn't kidding around: The Johnson & Johnson subsidiary makes and sells treatments for serious and chronic diseases. Its top-seller is Procrit, an anemia treatment often prescribed to cancer patients receiving chemotherapy. Other products include Leustatin, an injectable treatment for hairy cell leukemia; Orthoclone OKT3, a monoclonal antibody used to fight organ transplant rejection; Sporanox, an IV antibody for grave fungal infections; and Doxil, a liposomal chemotherapy approved for the treatment of ovarian cancer and an AIDS-related cancer called Kaposi's sarcoma. The company's R&D efforts focus on better treatments for cancer and anemia, as well as for a wide range of other diseases.
View the Comprehensive Company Description for Ortho Biotech
The Company Description provides a historical perspective of Ortho Biotech's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Ortho Biotech's evolution in the marketplace.
